Drupal.behaviors.print = function(context) {window.print();window.close();}>
Affy to Expand into Flow Cytometry, Immunology Markets with Planned $330M eBioscience Acquisition
December 06, 2011
Affy to Expand into Flow Cytometry, Immunology Markets with Planned $330M eBioscience Acquisition
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Royalties Drive up GeneNews Q1 Revenues Sharply
May 16, 2013 / GenomeWeb Daily News
Fluidigm Sees 2013 as 'Watershed Year' for Single-Cell Genomics, as C1 Sales Drive Q1 Revenues
May 7, 2013 / BioArray News
Fluidigm Reports 33 Percent Spike in Q1 Revenues
May 2, 2013 / GenomeWeb Daily News
Luminex, Posting Q1 Revenue Growth, Provides Updates on Gastro Pathogen, NeoPlex Assays
April 30, 2013 / BioArray News
Luminex's Q1 Revenues Rise 9 Percent on Jump in Royalties, Assay Sales
April 30, 2013 / GenomeWeb Daily News